Hematological Parameters in Axial Spondyloarthritis

Sponsor
Bozyaka Training and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05450133
Collaborator
(none)
300
2
1
150
147.3

Study Details

Study Description

Brief Summary

Axial spondyloarthritis is an inflammatory disease characterized by the involvement of the sacroiliac joints and the spine. Disease activity and structural changes are determined by using physical examination, imaging studies, laboratory parameters, and patient-reported indices. Among laboratory studies, Erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) are the most commonly utilized parameters. However, the level of ESR and CRP are inadequate in demonstrating disease activity and inflammation compared to other diseases. In this study, the investigators aimed to analyze and compare the systemic inflammatory index (SII), which is a hematologic parameter between subjects with radiographic axial spondyloarthritis, non-radiographic axial spondyloarthritis, and healthy controls. Secondarily, the relationship between disease activity and enthesitis score and SII scores in patients with radiographic and non-radiographic axial spondyloarthritis will be investigated.

Condition or Disease Intervention/Treatment Phase
  • Other: Systemic inflammatory index
  • Other: BASDAI
  • Other: ASDAS-ESR
  • Other: ASDAS-CRP
  • Other: MASES

Detailed Description

Axial spondyloarthritis is an inflammatory disease characterized by the involvement of the sacroiliac joints and the spine. Disease activity and structural changes are determined by using physical examination, imaging studies, laboratory parameters, and patient-reported indices. Among laboratory studies, Erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) are the most commonly utilized parameters. ESR and CRP are within the normal range in 40-50% of patients with spondyloarthritis and may remain within the normal range even during active disease. Therefore, the use of biomarkers suitable for the pathophysiology of the disease have been recommended. However, these tests are difficult to access and there is no consensus on showing disease activity. Systemic inflammatory index (SII) is a novel hematologic parameter and previous studies reported the relationship with disease activity in rheumatologic diseases, but the results are inconsistent.

This study will compare the SII between subjects with radiographic and non-radiographic axial spondyloarthritis with healthy subjects. Secondly, the study will investigate the relationship between SII, a new inflammation parameter, and disease activity in patients diagnosed with radiographic and non-radiographic axial spondyloarthritis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Relationship Between Systemic Inflammatory Index and Disease Activity in Axial Spondyloarthritis
Actual Study Start Date :
Jul 15, 2022
Anticipated Primary Completion Date :
Aug 15, 2022
Anticipated Study Completion Date :
Aug 15, 2022

Arms and Interventions

Arm Intervention/Treatment
R-ax-Spa

Radiographic axial spondyloarthritis

Other: Systemic inflammatory index
neutrophil count x platelet count/lymphocyte count

Other: BASDAI
Bath Ankylosing Spondylitis Disease Activity Index includes six questions which includes the following six parameters: fatigue, spinal pain, peripheral joint pain, attachment point inflammation, and duration and severity of morning stiffness. A total score, ranging from 0 to 10, was calculated according to the patients' responses to six questions, with a higher score indicating more severe illness.
Other Names:
  • Bath Ankylosing Spondylitis Disease Activity Index
  • Other: ASDAS-ESR
    The ASDAS-ESR is deduced using formula that is chosen by the ASAS group. ASDAS-ESR is calculated with the answers of spinal, peripheral pain, morning stiffness on BASDAI, the patient global assessment, and erythrocyte sedimentation rate (mm/h).
    Other Names:
  • Ankylosing Spondylitis Disease Activity Score-ESR
  • Other: ASDAS-CRP
    The ASDAS-CRP is deduced using formula that is chosen by the ASAS group. ASDAS-CRP is calculated with the answers of spinal, peripheral pain, morning stiffness on BASDAI, the patient global assessment, and erythrocyte C-reactive protein (mg/dl).
    Other Names:
  • Ankylosing Spondylitis Disease Activity Score-CRP
  • Other: MASES
    It is used to evaluate the sensitivity of enthesis points by palpation in patients with ankylosing spondylitis. Scoring is done by giving 1 point for sensitive areas and 0 points if there is no sensitivity on the fifth lumbar spinous process, bilateral first and seventh costochondral joints, iliac crystals, posterior and anterior iliac spines, attachment sites of achilles tendon to the calcaneus.
    Other Names:
  • Maastricht Ankylosing Spondylitis Entheses Score
  • nR-ax-Spa

    Non-radiographic axial spondyloarthritis

    Other: Systemic inflammatory index
    neutrophil count x platelet count/lymphocyte count

    Other: BASDAI
    Bath Ankylosing Spondylitis Disease Activity Index includes six questions which includes the following six parameters: fatigue, spinal pain, peripheral joint pain, attachment point inflammation, and duration and severity of morning stiffness. A total score, ranging from 0 to 10, was calculated according to the patients' responses to six questions, with a higher score indicating more severe illness.
    Other Names:
  • Bath Ankylosing Spondylitis Disease Activity Index
  • Other: ASDAS-ESR
    The ASDAS-ESR is deduced using formula that is chosen by the ASAS group. ASDAS-ESR is calculated with the answers of spinal, peripheral pain, morning stiffness on BASDAI, the patient global assessment, and erythrocyte sedimentation rate (mm/h).
    Other Names:
  • Ankylosing Spondylitis Disease Activity Score-ESR
  • Other: ASDAS-CRP
    The ASDAS-CRP is deduced using formula that is chosen by the ASAS group. ASDAS-CRP is calculated with the answers of spinal, peripheral pain, morning stiffness on BASDAI, the patient global assessment, and erythrocyte C-reactive protein (mg/dl).
    Other Names:
  • Ankylosing Spondylitis Disease Activity Score-CRP
  • Other: MASES
    It is used to evaluate the sensitivity of enthesis points by palpation in patients with ankylosing spondylitis. Scoring is done by giving 1 point for sensitive areas and 0 points if there is no sensitivity on the fifth lumbar spinous process, bilateral first and seventh costochondral joints, iliac crystals, posterior and anterior iliac spines, attachment sites of achilles tendon to the calcaneus.
    Other Names:
  • Maastricht Ankylosing Spondylitis Entheses Score
  • Control

    Healthy Controls

    Other: Systemic inflammatory index
    neutrophil count x platelet count/lymphocyte count

    Outcome Measures

    Primary Outcome Measures

    1. Systemic inflammatory index [Baseline]

      neutrophils * platelets/lymphocytes

    Secondary Outcome Measures

    1. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) [Baseline]

      The overall BASDAI score ranges from 0 to 10. Lower scores indicate less disease activity.

    2. Ankylosing Spondylitis Disease Activity Score (ASDAS)-ESR [Baseline]

      <1.3 between "inactive disease" and "low disease activity", <2.1 between "moderate disease activity" and "high disease activity", and >3.5 between "high disease activity" and "very high disease activity".

    3. Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP [Baseline]

      <1.3 between "inactive disease" and "low disease activity", <2.1 between "moderate disease activity" and "high disease activity", and >3.5 between "high disease activity" and "very high disease activity".

    4. Maastricht Ankylosing Spondylitis Entheses Score (MASES) [Baseline]

      Maastricht Ankylosing Spondylitis Entheses Score MASES ranging from 0 (0 sites with tenderness) to 13 (worst possible score; 13 sites with tenderness). Negative values indicate better outcome.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Diagnosed with axial spondyloarthritis according to the ASAS classification criteria
    Exclusion Criteria:
    • Acute/chronic infections

    • Presence of other autoimmune diseases

    • Diabetes mellitus

    • Coronary arterial disease

    • Hypertension

    • Malignancy

    • Hematological diseases

    • Liver diseases

    • Pregnancy/Lactation

    • Renal diseases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Izmir Bozyaka Research and Training Hostpital İzmir Turkey
    2 Izmir Bozyaka Research and Training Hostpital İzmir Turkey

    Sponsors and Collaborators

    • Bozyaka Training and Research Hospital

    Investigators

    • Principal Investigator: Bugra Ince, University of Health Sciences Izmir Bozyaka Training and Research Hospital
    • Study Director: Seniz Akcay, University of Health Sciences Izmir Bozyaka Training and Research Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Buğra İnce, Medical Doctor, Specialist, Bozyaka Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT05450133
    Other Study ID Numbers:
    • 2022/PMR_AS
    First Posted:
    Jul 8, 2022
    Last Update Posted:
    Jul 29, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Buğra İnce, Medical Doctor, Specialist, Bozyaka Training and Research Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 29, 2022